Care after a child's liver transplant must balance liver protection with fewer long-term treatment harms. That is the main message of a 2026 guideline on children's care after liver transplants. It updates guidance published in 2013. The focus spans the transplant itself through the move into adult care. This is a review and expert guidance, not a new treatment experiment. A team of child liver transplant experts and a medical librarian reviewed worldwide evidence. They then rated the evidence and voted on recommendations. Much of the evidence came from past health records or studies following people over time. Some guidance drew on findings from other groups of people. The source summary gives no measured changes in liver blood tests or treatment success rates. The guideline highlights reducing exposure to medicines that prevent the body from rejecting the new liver. The goal is to limit their long-term side effects while protecting the liver. Other priorities include preventing infections, supporting early nutrition and development, and easing the move to adult care. Infection prevention includes Preventive Vaccines. For members tracking AST (Aspartate Aminotransferase), this source offers context rather than a target number. It does not report how any specific routine changes this blood marker. Its message is broader: long-term care considers both liver protection and daily quality of life. On BioSocial, members can keep their own bloodwork history alongside notes about treatment changes and daily life. Comparing notes can help describe shared experiences, without treating another person's numbers as a goal. If liver transplant care is part of your family's experience, what has helped you keep track of bloodwork and daily well-being?